SaRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription

Cell Research

Volumn 26, Issue 3, 2016, Pages 320-335

  Portnoy, Victoria ^a   Lin, Szu Hua Sharon ^a   Li, Kathy H ^a   Burlingame, Alma ^a   Hu, Zheng Hui ^a   Li, Hao ^c   Li, Long Cheng ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ago2; Argonaute; promoter; promoter targeted RNA; RITA; RNAa; RNAP II; saRNA; transcription

Indexed keywords

ARGONAUTE PROTEIN; CDKN1A PROTEIN, HUMAN; CHROMATIN; CTR9 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DEAD BOX PROTEIN; DHX9 PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; PHOSPHOPROTEIN; RNA; RNA POLYMERASE II; SMALL UNTRANSLATED RNA; TUMOR PROTEIN;

BIOTINYLATION; CHROMATIN; GENETICS; HUMAN; METABOLISM; PROMOTER REGION; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UBIQUITINATION;

ARGONAUTE PROTEINS; BIOTINYLATION; CELL LINE, TUMOR; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEAD-BOX RNA HELICASES; HISTONES; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RNA; RNA POLYMERASE II; RNA, SMALL UNTRANSLATED; TRANSCRIPTION ELONGATION, GENETIC; TRANSCRIPTION INITIATION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84960111950     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2016.22     Document Type: Article

References (79)

1. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007; 130:77-88.
2. Nechaev S, Fargo DC, dos Santos G, Liu L, Gao Y, Adelman K. Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. Science 2010; 327:335-338.
3. Core LJ, Lis JT. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 2008; 319:1791-1792.
4. Buskirk AR, Kehayova PD, Landrigan A, Liu DR. In vivo evolution of an RNA-based transcriptional activator. Chem Biol 2003; 10:533-540.
5. Besch R, Giovannangeli C, Schuh T, Kammerbauer C, Degitz K. Characterization and quantification of triple helix formation in chromosomal DNA. J Mol Biol 2004; 341:979-989.
6. Kaihatsu K, Janowski BA, Corey DR. Recognition of chromosomal DNA by PNAs. Chem Biol 2004; 11:749-758.
7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806-811.
8. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002; 297:1833-1837.
9. Zilberman D, Cao X, Jacobsen SE. ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation. Science 2003; 299:716-719.
10. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004; 305:1289-1292.
11. Janowski BA, Huffman KE, Schwartz JC, et al. Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat Chem Biol 2005; 1:216-222.
12. Kim DH, Villeneuve LM, Morris KV, Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 2006; 13:793-797.
13. Li LC, Okino ST, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 2006; 103:17337-17342.
14. Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 2007; 3:166-173.
15. Yin H, Lin H. An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature 2007; 450:304-308.
16. Shibuya K, Fukushima S, Takatsuji H. RNA-directed DNA methylation induces transcriptional activation in plants. Proc Natl Acad Sci USA 2009; 106:1660-1665.
17. Seth M, Shirayama M, Gu W, Ishidate T, Conte D, Jr, Mello CC. The C. elegans CSR-1 argonaute pathway counteracts epigenetic silencing to promote germline gene expression. Dev Cell 2013; 27:656-663.
18. Turner MJ, Jiao AL, Slack FJ. Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle 2014; 13:772-781.
19. Tolia NH, Joshua-Tor L. Slicer and the argonautes. Nat Chem Biol 2007; 3:36-43.
20. Pal-Bhadra M, Leibovitch BA, Gandhi SG, et al. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 2004; 303:669-672.
21. Verdel A, Jia S, Gerber S, et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 2004; 303:672-676.
22. Place RF, Noonan EJ, Foldes-Papp Z, Li LC. Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol 2010; 11:518-526.
23. Huang V, Qin Y, Wang J, et al. RNAa is conserved in mammalian cells. PLoS One 2010; 5:e8848.
24. Turunen MP, Lehtola T, Heinonen SE, et al. Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res 2009; 105:604-609.
25. Chu Y, Yue X, Younger ST, Janowski BA, Corey DR. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res 2010; 38:7736-7748.
26. Li LC. The multifaceted small RNAs. RNA Biol 2008; 5:61-64.
27. Wang J, Place RF, Huang V, et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 2010; 70:10182-10191.
28. Wang X, Wang J, Huang V, Place RF, Li LC. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J 2012; 443:821-828.
29. Kang MR, Yang G, Place RF, et al. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res 2012; 72:5069-5079.
30. Reebye V, Saetrom P, Mintz PJ, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology 2014; 59:216-227.
31. Wang T, Li M, Yuan H, et al. saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol 2013.
32. Huang V, Place RF, Portnoy V, et al. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 2012; 40:1695-1707.
33. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 2008; 105:1608-1613.
34. Hu J, Chen Z, Xia D, Wu J, Xu H, Ye ZQ. Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation. Biochem J 2012; 447:407-416.
35. Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. RNA 2003; 9:1034-1048.
36. Chen PY, Weinmann L, Gaidatzis D, et al. Strand-specific 5?-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity. RNA 2008; 14:263-274.
37. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115:209-216.
38. Ahlenstiel CL, Lim HG, Cooper DA, Ishida T, Kelleher AD, Suzuki K. Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells. Nucleic Acids Res 2011.
39. Landthaler M, Gaidatzis D, Rothballer A, et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 2008; 14:2580-2596.
40. Hock J, Weinmann L, Ender C, et al. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep 2007; 8:1052-1060.
41. Ameyar-Zazoua M, Rachez C, Souidi M, et al. Argonaute proteins couple chromatin silencing to alternative splicing. Nat Struct Mol Biol 2012; 19:998-1004.
42. Jain A, Bacolla A, Chakraborty P, Grosse F, Vasquez KM. Human DHX9 helicase unwinds triple-helical DNA structures. Biochemistry 2010; 49:6992-6999.
43. Huo L, Wang YN, Xia W, et al. RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus. Proc Natl Acad Sci USA 2010; 107:16125-16130.
44. Zhang S, Grosse F. Nuclear DNA helicase II unwinds both DNA and RNA. Biochemistry 1994; 33:3906-3912.
45. Marton HA, Desiderio S. The Paf1 complex promotes displacement of histones upon rapid induction of transcription by RNA polymerase II. BMC Mol Biol 2008; 9:4.
46. Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell 2008; 29:653-663.
47. Benhamed M, Herbig U, Ye T, Dejean A, Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat Cell Biol 2012; 14:266-275.
48. Meister G, Landthaler M, Peters L, et al. Identification of novel argonaute-associated proteins. Curr Biol 2005; 15:2149-2155.
49. Schwartz JC, Younger ST, Nguyen NB, et al. Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 2008; 15:842-848.
50. Zhang SS, Grosse F. Purification and characterization of two DNA helicases from calf thymus nuclei. J Biol Chem 1991; 266:20483-20490.
51. Tang W, You W, Shi F, et al. RNA helicase A acts as a bridging factor linking nuclear beta-actin with RNA polymerase II. Biochem J 2009; 420:421-428.
52. Myohanen S, Baylin SB. Sequence-specific DNA binding activity of RNA helicase A to the p16INK4a promoter. J Biol Chem 2001; 276:1634-1642.
53. Tetsuka T, Uranishi H, Sanda T, et al. RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator. Eur J Biochem 2004; 271:3741-3751.
54. Zhong X, Safa AR. RNA helicase A in the MEF1 transcription factor complex up-regulates the MDR1 gene in multidrug-resistant cancer cells. J Biol Chem 2004; 279:17134-17141.
55. Aratani S, Fujii R, Oishi T, et al. Dual roles of RNA helicase A in CREB-dependent transcription. Mol Cell Biol 2001; 21:4460-4469.
56. Fujii R, Okamoto M, Aratani S, et al. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J Biol Chem 2001; 276:5445-5451.
57. Valineva T, Yang J, Silvennoinen O. Characterization of RNA helicase A as component of STAT6-dependent enhanceosome. Nucleic Acids Res 2006; 34:3938-3946.
58. Nakajima T, Uchida C, Anderson SF, et al. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 1997; 90:1107-1112.
59. Robb GB, Rana TM. RNA helicase A interacts with RISC in human cells and functions in RISC loading. Mol Cell 2007; 26:523-537.
60. Kuroda MI, Kernan MJ, Kreber R, Ganetzky B, Baker BS. The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila. Cell 1991; 66:935-947.
61. Zhang S, Grosse F. Molecular characterization of nuclear DNA helicase II (RNA helicase A). Methods Mol Biol 2010; 587:291-302.
62. Kim J, Guermah M, Roeder RG. The human PAF1 complex acts in chromatin transcription elongation both independently and cooperatively with SII/TFIIS. Cell 2010; 140:491-503.
63. Mueller CL, Jaehning JA. Ctr9, Rtf1, and Leo1 are components of the Paf1/RNA polymerase II complex. Mol Cell Biol 2002; 22:1971-1980.
64. Krogan NJ, Kim M, Ahn SH, et al. RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol Cell Biol 2002; 22:6979-6992.
65. Rondon AG, Gallardo M, Garcia-Rubio M, Aguilera A. Molecular evidence indicating that the yeast PAF complex is required for transcription elongation. EMBO Rep 2004; 5:47-53.
66. Zhang Y, Sikes ML, Beyer AL, Schneider DA. The Paf1 complex is required for efficient transcription elongation by RNA polymerase I. Proc Natl Acad Sci USA 2009; 106:2153-2158.
67. Jaehning JA. The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim Biophys Acta 2010; 1799:379-388.
68. Chu Y, Simic R, Warner MH, Arndt KM, Prelich G. Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes. EMBO J 2007; 26:4646-4656.
69. Massoni-Laporte A, Perrot M, Ponger L, Boucherie H, Guieysse-Peugeot AL. Proteome analysis of a CTR9 deficient yeast strain suggests that Ctr9 has function(s) independent of the Paf1 complex. Biochim Biophys Acta 2012; 1824:759-768.
70. Musso M, Bianchi-Scarra G, Van Dyke MW. The yeast CDP1 gene encodes a triple-helical DNA-binding protein. Nucleic Acids Res 2000; 28:4090-4096.
71. Piro AS, Mayekar MK, Warner MH, Davis CP, Arndt KM. Small region of Rtf1 protein can substitute for complete Paf1 complex in facilitating global histone H2B ubiquitylation in yeast. Proc Natl Acad Sci USA 2012; 109:10837-10842.
72. Wood A, Schneider J, Dover J, Johnston M, Shilatifard A. The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J Biol Chem 2003; 278:34739-34742.
73. Batta K, Zhang Z, Yen K, Goffman DB, Pugh BF. Genome-wide function of H2B ubiquitylation in promoter and genic regions. Genes Dev 2011; 25:2254-2265.
74. Minsky N, Shema E, Field Y, Schuster M, Segal E, Oren M. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol 2008; 10:483-488.
75. van der Oost J. Molecular biology. New tool for genome surgery. Science 2013; 339:768-770.
76. Matsui M, Sakurai F, Elbashir S, Foster DJ, Manoharan M, Corey DR. Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol 2010; 17:1344-1355.
77. Zhang X, Li H, Burnett JC, Rossi JJ. The role of antisense long noncoding RNA in small RNA-triggered gene activation. RNA 2014; 20:1916-1928.
78. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 2011; 44:667-678.
79. Strobl LJ, Eick D. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J 1992; 11:3307-3314.